Last reviewed · How we verify

NCT07437599

Effect of Coffee Smelling on Pain, Physiological Parameters and Time to Discharge From Post Anesthesia Care Unit in Patients Undergoing Laparoscopic Cholecystectomy

Active, enrolled NA Last updated 3 March 2026
What this trial tests

NA trial testing Coffee Smell in Cholecystectomy, Laparoscopic in 66 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
22 February 2026
Primary endpoint
30 June 2026
30 August 2026

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment66
Start date22 February 2026
Primary completion30 June 2026
Estimated completion30 August 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

18 and older, any sex, with Cholecystectomy, Laparoscopic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research was designed as a randomized controlled trial to determine the effects of coffee sniffing on pain and physiological parameters in patients undergoing cholecystectomy surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cholecystectomy, Laparoscopic

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07437599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing